UBS cuts target for Omega Healthcare Investors stock to USD 52.00
Published on 10/15/2026 at 22:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and company dates
- UBS lowered its Omega Healthcare Investors target from USD 54.00 to USD 52.00 on October 13, 2026.
- Second-quarter 2026 revenue reached USD 328.25 million, up 16.20 percent year over year.
- Omega Healthcare Investors stock costs EUR 40.55 at Lang & Schwarz on October 15, 2026 at 10:18 p.m. CEST.
- Omega Healthcare Investors will report third-quarter 2026 results on November 4, 2026, at 10:00 a.m. ET.
UBS lowered its price target for Omega Healthcare Investors from USD 54.00 to USD 52.00 on October 13, 2026, while maintaining a Buy rating. The target stands 14.21 percent above the USD 45.53 home-exchange price, calculated from the latest quoted level. According to MarketBeat, UBS kept its Buy rating while cutting the target from USD 54.00 to USD 52.00.
Second-quarter revenue rose 16.20 percent
Omega's second-quarter 2026 revenue was USD 328.25 million, up 16.20 percent from the same quarter a year earlier. Diluted earnings per share came to USD 1.19, compared with USD 0.51 consensus, while net income attributable to common shareholders was USD 362.82 million.
The earnings comparison needs context. Omega's second-quarter result included a gain on facility sales, so the reported net income figure does not describe recurring operating performance alone. The reported revenue, earnings-per-share and consensus figures were carried by MarketBeat.
Price sits inside the 52-week range
On the NYSE, OHI last traded at USD 45.53 on October 15, 2026 at 4:00 p.m. ET. Its 52-week range was USD 39.26 to USD 52.39, while the latest volume was 1,374,553 shares against an average of 1,945,295.
Valuation and November results date
Omega had a market capitalization of USD 13.8 billion, a price-to-earnings ratio of 16.26 and a dividend yield of 6.00 percent as of October 15, 2026. The company lists its third-quarter 2026 earnings call for November 4, 2026, at 10:00 a.m. ET, according to its investor-relations page.
Comparison with peers
OHI (NYSE, USD): price-to-earnings ratio 16.26, market capitalization USD 13.8 billion.
LTC (NYSE, USD): plus 0.32 percent, price-to-earnings ratio 15.53, market capitalization USD 2.3 billion.
NHI (NYSE, USD): plus 0.47 percent, price-to-earnings ratio 18.98, market capitalization USD 3.2 billion.
Price remains the market frame
Omega Healthcare Investors was trading at EUR 40.55 at Lang & Schwarz on October 15, 2026 at 10:18 p.m. CEST. The euro quotation provides the Germany-focused market view, while the NYSE price and the 52-week range put the valuation in its home-market context.
The further course of trading is shown by the continuously updated real-time quote of Omega Healthcare Investors stock.
Omega Healthcare Investors stock facts
- Company: Omega Healthcare Investors, Inc.
- ISIN: US6819361006
- Ticker: OHI
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 15, 2026, 10:18 p.m. CEST): EUR 40.55
- Market capitalization: USD 13.8 billion (as of October 15, 2026)
- 52-week range: USD 39.26-52.39 (as of October 15, 2026)
- Sector / Industry: Real Estate / Healthcare Facilities REIT
- Next earnings date: November 4, 2026
Market context: Market report S&P 500.
